FINWIRES · TerminalLIVE
FINWIRES

SGX:ADN

7 stories mentioning SGX:ADNUpdated 40d ago

Every FINWIRES story that references SGX:ADN, newest first.

What's the latest news on SGX:ADN?

Asia Markets

Singapore Shares Mute as Regional Uncertainty Weighs Down Sentiment

Singapore shares remained little changed on Tuesday, with investor sentiment remaining cautious over uncertainty in the Middle East and lofty AI valuations.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 5,603.01 and 5,633.84 throughout the day. It ended the session at 5,612.25, down 0.03 points or 0% compared to Monday's close.On the corporate front, shares of Koh Brothers Eco Engineering (SGX:5HV) were down nearly 10% at the close with the engineering solutions provider flagging a net loss for the first half of the year.APAC Realty's (SGX:CLN) shares closed nearly 7% higher as its attributable profit to owners fell 17% during the first half of the year to SG$9.4 million from SG$11.3 million a year earlier.Meanwhile, shares of First Sponsor Group (SGX:ADN) were up nearly 5% at the close as it proposed a renounceable, non-underwritten rights issue of up to SG$332.6 million in 4.85% perpetual convertible capital securities.

^STISGX:5HVSGX:ADNSGX:CLN
Asia

First Sponsor Group Filed Appeal Against Humen Oasis Mansion Units' Court Ruling; Shares Up 5%

First Sponsor Group's (SGX:ADN) subsidiaries have filed an appeal with the Dongguan Intermediate People's Court challenging earlier judgments on the residential units in the Humen Oasis Mansion Project, according to a Monday filing to the Singapore stock exchange.The company's shares were up nearly 5% in Tuesday's trade.The company said it will "vigorously defend" its position and update investors.A July 20 order by the Dongguan No. 2 People's Court was not in favor of the company, and it ruled that the project company and its subsidiaries "engaged in malicious collusion" for the sale and purchase of the residential units, making the transactions invalid.

SGX:ADN
Asia

First Sponsor Group Proposes SG$333 Million Convertible Securities Rights Issue

First Sponsor Group (SGX:ADN) proposed a renounceable, non-underwritten rights issue of up to SG$332.6 million in 4.85% perpetual convertible capital securities, according to a Singapore Exchange filing on Monday.The rights issue offers one perpetual convertible capital security for every five existing shares at an issue price of SG$1.08 each, the release said.Proceeds will fund expansion of the group's property‑holding, development and financing businesses and repay related borrowings.United Overseas Bank (SGX:U11) has been appointed as the manager for the rights issue.Shares of United Overseas Bank rose nearly 1% in recent trade.

SGX:ADNSGX:U11
Asia

First Sponsor Swings to Loss in H1 as Revenue Drops 11%

First Sponsor Group (SGX:ADN) swung to an attributable loss of SG$92.8 million in the first half compared with a profit of nearly SG$19 million a year earlier.The investment holdings company's loss per share was SG$0.0874, compared with earnings per share of SG$0.0116 a year earlier, according to a Singapore Exchange filing on Monday.Revenue declined 11% to SG$136.7 million from SG$153.9 million.The company declared a dividend of SG$0.011 Singapore cents per ordinary share, payable from Sept. 25.

SGX:ADN
Asia Markets

Singapore Shares Gain More Than 1% as AI Boom Extends; MetaOptics Soars 11%

Singapore shares extended gains on Wednesday, soaring more than 1% at the close, despite mixed results across the region as chipmakers influencing investor sentiment.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 5,483.04 and 5,595.42 throughout the day. It ended the session at 5,595.42, up 68.70 points or 1.2% compared to Tuesday's close.On the corporate front, shares of MetaOptics (SGX:9MT) surged over 11% at the close as it agreed to deploy its metalens direct laser writer system at the University of Arizona's Center of Semiconductor Manufacturing.First Sponsor (SGX:ADN) expects to recognize an impairment charge of roughly SG$36.7 million in its first-half financial statements following an adverse ruling by a court in Dongguan, China.Meanwhile, Lonza's (SGX:O6Z) attributable profit to equity holders during the first half of the year rose to 591 million Swiss francs from 426 million francs a year earlier.

^STISGX:9MTSGX:ADNSGX:O6Z
Asia

First Sponsor Faces SG$36.7 Million H1 Impairment After Chinese Court Voids Property Deal

First Sponsor (SGX:AND) expects to recognize an impairment charge of roughly SG$36.7 million in its first-half financial statements following an adverse ruling by a court in Dongguan, China, according to a Tuesday filing with the Singapore Exchange.The Dongguan No. 2 People's Court invalidated the purchase of residential units in the Humen Oasis Mansion project by First Sponsor's subsidiaries, ruling that the transaction involved malicious collusion with the project developer.The court ordered the property titles re-registered under the project company's name within 30 days.First Sponsor paid 292.1 million yuan for the properties. With the court giving no instructions on returning the funds, the group considers a meaningful recovery unlikely.First Sponsor is currently reviewing the judgment with legal advisors to evaluate an appeal.

SGX:ADN
Asia

First Sponsor Group Expects to Post H1 Loss

First Sponsor Group (SGX:ADN) expects to report a net loss for the first half of 2026, according to a Singapore bourse filing.The company attributed the expected loss mainly to fair value and foreign exchange losses on derivatives.The property developer plans to release financial figures around Aug. 3.

SGX:ADN

Track with the FINWIRES app suite

FolioX
FolioX
Track SGX:ADN in your portfolio
WheelAI
WheelAI
Analyze SGX:ADN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SGX:ADN